Filing Details
- Accession Number:
- 0001601485-21-000081
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-07 16:06:40
- Reporting Period:
- 2021-12-06
- Accepted Time:
- 2021-12-07 16:06:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1601485 | Angion Biomedica Corp. | ANGN | Pharmaceutical Preparations (2834) | 113430072 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1607858 | Itzhak Goldberg | C/O Angion Biomedica Corp. 51 Charles Lindbergh Blvd. Uniondale NY 11553 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-12-06 | 32,118 | $3.35 | 1,720,068 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The shares reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2021 by the Reporting Person
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.21 to $3.45 inclusive.